Home >> Life Sciences >> Healthcare

Global Drug Discovery Market Report: 2016 Edition

Published: Dec-2015 | Format: PDF | Gen Consulting | Code: MRS - 86680

Gen's report, 'Global Drug Discovery Market Report: 2016 Edition' provides detailed market and segment level data on the Global and Chinese consumption of Drug Discovery. The report provides historic, forecast and growth patterns by company, country and type/application from 2016 to 2021.
This report delivers an extensive overview of Global Drug Discovery industry with a focus on China. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. It also helps the companies to better understand the trends of Soups market to seize opportunities and formulate crucial business strategies.
With this report, you will get access to:
1. Market overview including definition, industrial chain (upstream & downstream), manufacturing technology details and the costs analysis from the aspects of raw materials, labor costs and depreciation.
2. Value and volume consumption status and trends of the market, including Global and Chinese top players’ capacity & production, price & production value, cost & profit and market shares from 2011 to 2016.3. Worldwide supply/demand pattern of Drug Discovery by country or region (North America, China, EMEA, Asia except China), and by application/type.
4. Growth, trends and forecast of 2016-2021 Drug Discovery market and some important proposals for new investment of Drug Discovery Industry before evaluating its feasibility.
Overall, the report provides an in-depth insight of 2011-2021 Global and Chinese Drug Discovery industry covering all important parameters.
Chapter One Description
1.1 Study Scope
1.2 Key Findings of Drug Discovery Industry

Chapter Two Brief Introduction
2.1 Definition
2.2 Industry Chain Structure
2.2.1 Upstream Raw Materials
2.2.2 Downstream Market

Chapter Three Development and Trends
3.1 Key Manufacturing Technologies
3.2 Issues and Trends

Chapter Four Cost Structure
4.1 Bill of Materials (BOM)
4.3 Labor Costs
4.4 Depreciation Costs
4.5 Manufacturing Costs

Chapter Five Worldwide Key Vendors
Company A
Company B
Company C
Company D
Company E
Company F
Company G
…

Chapter Six Market Overview
6.1 Global Market Size
6.2 Chinese Market Size

Chapter Seven Market Status
7.1 Market Competition Status by Key Vendors
7.2 Regional Market Competition Status
   China
   North American
   EMEA
   Asia except China

Chapter Eight Consumption Pattern
8.1 Regional Consumption
8.2 Global Consumption by Application
8.3 Chinese Consumption by Application

Chapter Nine Market Forecast
9.1 Market Size Forecast
9.2 Regional Consumption Forecast
9.3 Global Consumption Forecast by Application
9.4 Chinese Consumption Forecast by Application

Chapter Ten Development/Trends
10.1 Policies and Events
10.2 2015 New Situation

Chapter Eleven Investment Feasibility Analysis

Figures and Tables
Figure Global Market Size 2011-2016
Figure Chinese Market Size 2011-2016
Figure Global Key Application 2015
Figure Chinese Key Application 2015
Table Company A Production Status 2011-2016
Figure Company A Market Share 2011-2016
Table Company B Production Status 2011-2016
Figure Company B Market Share 2011-2016
Table Company C Production Status 2011-2016
Figure Company C Market Share 2011-2016
Table Company D Production Status 2011-2016
Figure Company D Market Share 2011-2016
Table Company E Production Status 2011-2016
Figure Company E Market Share 2011-2016
Table Company F Production Status 2011-2016
Figure Company F Market Share 2011-2016
Table Company G Production Status 2011-2016
Figure Company G Market Share 2011-2016
…
Table Global Key Vendors Capacity List 2011-2016
Table Global Key Vendors Capacity Share List 2011-2016
Figure Global Key Vendors Capacity Share 2011-2016
Table Global Key Vendors Production List 2011-2016
Table Global Key Vendors Production Share List 2011-2016
Figure Global Key Vendors Production Share 2011-2016
Table Global Key Vendors Production Value List 2011-2016
Table Global Key Vendors Production Value Share List 2011-2016
Figure Global Key Vendors Production Value Share 2011-2016
Figure Global Production, Production Value and Growth Rate 2011-2016
Table Global Average Price and Gross Margin 2011-2016
Table Chinese Key Vendors Capacity List 2011-2016
Table Chinese Key Vendors Capacity Share List 2011-2016
Figure Chinese Key Vendors Capacity Share 2011-2016
Table Chinese Key Vendors Production List 2011-2016
Table Chinese Key Vendors Production Share List 2011-2016
Figure Chinese Key Vendors Production Share 2011-2016
Table Chinese Key Vendors Production Value List 2011-2016
Table Chinese Key Vendors Production Value Share List 2011-2016
Figure Chinese Key Vendors Production Value Share List 2011-2016
Figure Chinese Production, Production Value and Growth Rate 2011-2016
Table Chinese Average Price and Gross Margin 2011-2016
Table Chinese Consumption 2011-2016
Figure Global Key Vendors Capacity Share 2015
Figure Global Key Vendors Production Share 2015
Figure Global Key Vendors Production Value Share 2015
Figure Chinese Key Vendors Capacity Share 2015
Figure Chinese Key Vendors Production Share 2015
Figure Chinese Key Vendors Production Value Share 2015
Table Regional Capacity (Units) List 2011-2016
Figure Regional Capacity (Units) 2011-2016
Table Regional Capacity Share List 2011-2016
Figure Regional Capacity Share 2011-2016
Table Regional Production (Units) List 2011-2016
Figure Regional Production (Units) 2011-2016
Table Regional Production Share List 2011-2016
Figure Regional Production Share 2011-2016
Table Regional Production Value (M USD) List 2011-2016
Figue Regional Production Value (M USD) 2011-2016
Table Regional Production Value Share List 2011-2016
Figure Regional Production Value Share 2011-2016
Table Regional Consumption Volume (Units) List 2011-2016
Figure Regional Consumption Volume (Units) 2011-2016
Table Regional Consumption Volume Share List 2011-2016
Figure Regional Consumption Volume Share 2011-2016
Table Global Consumption Volume (Units) List 2011-2016
Figure Global Consumption Volume (Units) 2011-2016
Table Global Consumption Volume Share List 2011-2016
Figure Global Consumption Volume Share 2011-2016
Table Chinese Consumption Volume (Units) List 2011-2016
Figure Chinese Consumption Volume (Units) 2011-2016
Table Chinese Consumption Volume Share List 2011-2016
Figure Chinese Consumption Volume Share 2011-2016
Figure Global Production, Production Value and Growth Rate 2016-2021
Figure Chinese Production, Production Value and Growth Rate 2016-2021
Table Global Average Price and Gross Margin 2016-2021
Table Chinese Average Price and Gross Margin 2016-2021
Table Consumption Volume (Units) List 2016-2021
Figure Consumption Volume (Units) 2016-2021
Table Consumption Volume Share List 2016-2021
Figure Consumption Volume Share 2016-2021
Table Global Consumption Volume (Units) List 2016-2021
Figure Global Consumption Volume (Units) 2016-2021
Table Global Consumption Volume Share List 2016-2021
Figure Global Consumption Volume Share 2016-2021
Table Chinese Consumption Volume (Units) List 2016-2021
Figure Chinese Consumption Volume (Units) 2016-2021
Table Chinese Consumption Volume Share List 2016-2021
Figure Chinese Consumption Volume Share 2016-2021
Table New Investment Feasibility Analysis

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 57 | Code : MRS-172735 | 3500

Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017 Summary Catenin Beta 1 (Beta Catenin or CTNNB1) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017, outlays comprehensive information on the Catenin Beta 1 (Beta Catenin or CTNNB1) targeted therapeutics, complete with analysis b Read more

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 74 | Code : MRS-172734 | 3500

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017 Summary According to the recently published report 'Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017'; Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Transthyretin is Read more

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 107 | Code : MRS-172733 | 3500

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2017 Summary Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Complement component 5 is a protein is encoded by the C5 gene. Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the fou Read more

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 42 | Code : MRS-172732 | 3500

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2017 Summary Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) pipeline Target constitutes close to 7 molecules. Out of which approximately 7 molecules are developed by Companies. The latest report Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2017, outlays comprehensive information on the Protein Kinase C Epsilon Type (nPKC Epsilon Read more

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 32 | Code : MRS-172731 | 3500

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary According to the recently published report 'Aurora Kinase C - Pipeline Review, H2 2017'; Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AUR Read more

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 58 | Code : MRS-172730 | 3500

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Glycogen synthase kinase 3 beta also known as GSK3B is an enzyme encoded by the GSK3B. It constitutively activate protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and reg Read more

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 50 | Code : MRS-172729 | 3500

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2017 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 11 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2017, outlays comprehensive information on the Glucokinase (Hex Read more

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 112 | Code : MRS-172728 | 3500

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2017 Summary According to the recently published report 'Telomerase Reverse Transcriptase - Telomerase Reverse Transcriptase'; Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) pipeline Target constitutes close to 31 molecules. Out of which approximately 25 m Read more

Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 36 | Code : MRS-172727 | 3500

Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Pipeline Review, H2 2017 Summary Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Dual specificity protein kinase TTK is an enzyme encoded by the TTK gene. It is associated with cell proliferation, essentia Read more

Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 145 | Code : MRS-172726 | 3500

Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2017 Summary Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) pipeline Target constitutes close to 31 molecules. Out of which approximately 27 molecules are developed by companies Read more

Single User | $(USD)2800 View Pricing